Evaluation of different chemical adjuvants on an avian influenza H6 DNA vaccine in chickens.
This study assessed the ability of three adjuvants (aluminium hydroxide, Essai (microparticle) and Phema (nanoparticle)) to enhance the immune response of chickens to an H6N2 avian influenza DNA vaccine. No haemagglutination inhibition antibody was detected following two intramuscular immunizations with the adjuvanted and non-adjuvanted pCAG-HAk vaccine, which has previously been shown to induce moderate H6 haemagglutinin antibody response in SPF chickens. Following virus challenge, neither the vaccinated group without adjuvant nor the Essai-adjuvanted group showed a statistically significant reduction in virus shedding in oropharyngeal and cloacal swabs compared with the naive control group. However, the aluminium hydroxide and Phema-adjuvanted groups significantly reduced the frequency of virus shedding in oropharyngeal swabs, indicating that these adjuvants appeared to further enhance the vaccine potency. Aluminium hydroxide holds promise as an adjuvant for enhancing DNA-induced immune response in chickens owing to its low price and safety record.
a School of Veterinary and Life Sciences , Murdoch University , Perth , Australia.
Songhua
S
Shan
a School of Veterinary and Life Sciences , Murdoch University , Perth , Australia.
Stan
S
Fenwick
a School of Veterinary and Life Sciences , Murdoch University , Perth , Australia.
Trevor
T
Ellis
a School of Veterinary and Life Sciences , Murdoch University , Perth , Australia.
Eddy
E
Poinern
a School of Veterinary and Life Sciences , Murdoch University , Perth , Australia.
John
J
Edwards
a School of Veterinary and Life Sciences , Murdoch University , Perth , Australia.
Xuan
X
Le
a School of Veterinary and Life Sciences , Murdoch University , Perth , Australia.
Zhongtao
Z
Jiang
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000145:classification; D000536:Aluminum Hydroxide / Q000008:administration & dosage; D000818:Animals; D002645:Chickens / Q000276:immunology* / Q000821:virology; D056724:Immunity, Humoral; D009980:Influenza A virus / Q000235:genetics / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology; D005585:Influenza in Birds / Q000517:prevention & control* / Q000821:virology; D053758:Nanoparticles / Q000008:administration & dosage; D010957:Plasmids / Q000235:genetics; D011201:Poultry Diseases / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination / Q000662:veterinary; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000276:immunology; D017201:Virus Shedding
D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines; D019444:Vaccines, DNA; D000536:Aluminum Hydroxide
Adjuvant; DNA vaccine; avian influenza; commercial chickens; nanovaccine